beta

AKTX

Akari Therapeutics Plc

Aktx

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Akari Therapeutics PLC is a biopharmaceutical company in clinical stage. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system.

Market Cap: 48.7 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.akaritx.com

Shares Outstanding: 15.3 Million

Float: 13.9 Million

Dividend: 0.0 (0.0%)

Beta: -8.834261

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 597 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1930 trading days

From: 2014-01-15 To: 2019-10-11

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-09-17 10.0 1.0 10.0
Data provided by IEX Cloud